American Congress of Obstetricians and Gynecologists. (2014). Practice Bulletin No. 145: Antepartum fetal surveillance. Obstet Gynecol, 124, 182–192.

American Congress of Obstetricians and Gynecologists. (2015). Committee Opinion No. 640: Cell-free DNA screening for fetal aneuploidy. Obstetrics and Gynecology, 126(3), e31–e37.

American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, & Society for Maternal-Fetal Medicine. (2020). Screening for fetal chromosomal abnormalities. Obstetrics and Gynecology, 136(4), e48–e69 (Revised in 2020).

American Congress of Obstetricians and Gynecologists. (2020). Prevention of early-onset group B streptococcal disease in newborns: ACOG Committee Opinion, Number 797. Obstetrics and Gynecology, 135(2), e51–e72. http://www.acog.org/-/media/project/acog/acogorg/clinical/files/committee-opinion/articles/2020/02/prevention-of-group-b-streptococcal-early-onset-disease-in-newborns.pdf

KrsticN., & ObicanS. G. (2020). Current landscape of prenatal genetic screening and testing. Birth Defects Research, 112(4), 321–331.

LandonM. B., GatonH. L., JauniauxE. R. M., DriscollD. A., BerghellaV., GrobmanW. A., KilpatrickS. J., & CahillA. G. (2020). Obstetrics: Normal and problem pregnancies (8th ed.). Elsevier Saunders.

McPhersonR. A., & PincusM. R. (2016). Henry’s clinical diagnosis and management by laboratory methods (23rd ed.). Saunders Elsevier.

Page-ChristiaensL., & KleinH. G., (Eds.). (2018). Noninvasive prenatal testing (NIPT): Applied genomics in prenatal screening and diagnosis. Academic Press.

StapletonG., DondropW., Schroder-BackP., & de WertG. (2019). A capabilities approach to prenatal screening for fetal abnormalities. Health Care Analysis, 27(4), 309–321.

WongE. C., BrugnaraC., StraseskiJ., KelloggM., AdeliK. (2020). Pediatric reference intervals (8th ed.). AACC Press.